Clients to Benefit from a Distinctive Union of Pharmaceutical, Biotech and Medical Device Experience in Professional Education, Brand Management and
Special Event Planning
NORTH BRANFORD, Conn., Nov. 19 /PRNewswire/ -- M2D management announces the official launch of a progressive marketing and communications firm that will focus on the life sciences sector. M2D is the brainchild of two individuals with clear records of success in this highly regulated sector, Christine Lawton and Timothy Roe.
Christine is a respected meetings and events professional with almost two decades of experience working on both the client and agency sides of the business. Her accomplishments span several hundred meetings and conventions of all varieties, both domestically and internationally, during her pharmaceutical tenure.
Timothy is a pharmaceutical and medical device professional with over 15 years of progressively responsible positions in Sales and Marketing. Timothy is known in the industry as having the business acumen to maximize a product's global commercial return and asset value. Timothy has managed the "Big-C" brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller niche products.
M2D provides tireless proactive thinking that eliminates problems associated with vendor complacency. Timothy Roe adds:
"As a former Product Manager, I recognize what is important to clients. Vendors should always add more detailed and proactive thought to their work, even after the 'honeymoon' period. There continues to be a tremendous need for much higher performance, and smaller firms like M2D are already there. Those who can do it cost-effectively will win."
M2D's uniqueness results from a lifetime of client-side interactions with vendors. Clients receive genuine strategic attention, but the difference lies with M2D's painstakingly detailed approach to tactical execution. The company utilizes the most advanced analytics and metric reporting tools available and offers them either gratis or at attractive pricing.
M2D's core capabilities include:
-- Thorough Understanding of Compliance Laws
-- Lowest Guaranteed Travel Rates
-- Investigator & Sales Meetings
-- Conventions & Symposia; Ad Boards & Round Tables
-- Opinion Leader & Speaker Bureau Management
-- Promotional Peer-to-Peer Events
-- CME-based Programming
-- Surrogate Brand Management and Audits
-- Advanced Webinars & Web Conferences with Real-Time Polling
M2D's website http://www.m2details.com.
Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- Plough respectively.
Contact: M2D Media Relations
|SOURCE Marketing and Meeting Details (M2D)|
Copyright©2007 PR Newswire.
All rights reserved